Leyla Alı qızı Mehdibəyli
Yüklə 1,34 Mb. Pdf görüntüsü
|
|
63
1. İslamzadə F.İ., Əfəndiyev A.M., İslamzadə F.Q. İnsan biokimyasının əsasları // Şirvannəşr, 2001, 76(362) 2.
Ateş Ö., Çorak A., Kulaksız H., Sercan C., Kapıcı S., Yüksel İ., Ulucan K. Sağlıklı Türk genç futbolcularda anksiyete ile ilişkili SLC6A4 geni promoter “S” ve “L” allelerinin saptanması // The journal of Neurobehavioral sciences, 2017, Volume:4, Issue Number:3 3. Özalp E. İntihar Davranışının Genetiği // Türk Psikiyatri Dergisi, 2009, 20(1): 85- 93 4. Yava
şcı E.Ö., Akkaya C. Şizofrenide Serotoninin Rolü // Current Approaches in Psychiatry 2012; 4(2): 237-259 5. Бутовская П.Р., Лазебный О.Е., Фехретдинова Д.И., Васильев В.А., Просикова Е.А., Лысенко В.В., Удина И.Г., Бутовская М.Л. Выявление ассоциации полиморфизма четырех генов серотониновой системы (5- HTTL, 5-HT1A, 5-HT2A и MAOA) с чертами личности у спортсменов силовых видов спорта // Молекулярная генетика, микробиология и вирусология №4, 2015, 33(4): 9-15 6. Abdolmaleky H.M., Faraone S.V., Glatt S.J., Tsuang M.T. Meta-analysis of association between the T102C polymorphism of the 5ht2a receptor gene and schizophrenia // Schizophr. Res., 2004, 67, 53 –62
7. Abdolmaleky H.M., Yaqubi S., Papageorgis P., Lambert A.W., Ozturk S., Sivaraman V., Thiagalingam S. Epigenetic dysregulation of HTR2A in the brain of patients with schizophrenia and bipolar disorder // Schizophr. Res., 2011, 129, 183
–190 8. Bah J., Lindström M., Westberg L., Mannerås L., Ryding E., Henningsson S., Melke J., Rosén İ., Träskman-Bendz L., Eriksson E. Serotonin transporter gene polymorphisms: Effect on serotonin transporter availability in the brain of suicide attempters // Psychiatry Res, 2008, 162(3): 221-9 64
9. Barnes N.M., Neumaier J.F. Neuronal 5-HT Receptors and SERT // Tocris Bioscience Scientific Review Series, 2011 10. Barnes N.M., Sharp T. A review of central 5-HT receptors and their function // Neuropharmacology, 1999, 38: 1083-1152 11. Berger M., Gray J.A., Roth B.L. The Expanded Biology of Serotonin // Annu. Rev. Med., 2009, 60: 355 –366
12. Bertola V., Cordeiro Q., Zung S., Miracca E.C., Vallada H. Association Analysis between the C516T polymorphism in the 5-HT2A receptor gene and Schizophrenia // Arq Neuropsiquiatr., 2007, 65(1): 11-14 13. Blasi G., De Virgilio C., Papazacharias A., Taurisano P., Gelao B., Fazio L., Ursini G., Sinibaldi L., Andriola I., Masellis R., et al. Converging evidence for the association of functional genetic variation in the serotonin receptor 2A gene with prefrontal function and olanzapine treatment // JAMA Psychiatry, 2013, 70, 921 – 930 14. Bombardi C. Neuronal localization of the 5-HT2 receptor family in the amygdaloid complex // Front. Pharmacol., 2014, 5:68 15. Bortolato M., Chen K., Shih J.C. The degradation of serotonin: role of MAO // In: Müller C, Jacobs B (eds) Handbook of behavioral neurobiology of serotonin. Elsevier B. V, Amsterdam, 2010, 203 –218
16. Bray N.J., Buckland P.R., Hall H., Owen M.J., O'Donovan M.C. The serotonin- 2A receptor gene locus does not contain common polymorphism affecting mRNA levels in adult brain // Mol Psychiatry, 2004, 9: 109-114 17. Caspi A, Sugden K, Moffitt TE, et al. Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene // Science, 2003, 301: 386 – 389 18. Cheah S-Y., Lawford B.R., Young R., Morris C.P., Voisey J. mRNA Expression and DNA Methylation Analysis of Serotonin Receptor 2A (HTR2A) in the Human Schizophrenic Brain // Genes, 2017, 8, 14
65
19. Correa H., Marco L.De, Boson W., Nicolato R., Teixeira A.L., Campo V.R., Romano-Silva M.A. Association study of T102C 5-HT2A polymorphism in schizophrenic patients: diagnosis, psychopathology, and suicidal behavior // Dialogues in clinical neuroscience, 2007, 9(1): 97-101 20. Davies M.A., Setola V., Strachan R.T., Sheffler D.J.,
Salay E., Hufeisen S.J., Roth B.L.
Pharmacologic analysis of nonsynonymous coding h5-HT2A SNPs reveals alterations in atypical antipsychotic and agonist efficacies // Pharmacogenomics J, 2006; 6: 42 –51 21. Dorocic I.P. Anatomical and functional characterization of serotonergic neurocircuitry // 2016 22. Gaspar P., Cases O., Maroteaux L. The developmental role of serotonin: news from mouse molecular genetics // Nature Reviews Neuroscience , 2003, 4 (12), 1002
–1012 23. Gaspar P. Genetic models to understand how 5-HT acts during development // J. Soc. Biol., 2004, 198, 18 –21
24. Gershon M.D., Tack J. The serotonin signaling system: from basic understanding to drug development for functional GI disorders // Gastroenterology, 2007, 132: 397 –414
25. Giorgetti M., Tecott L.H. Contributions of 5-HT2C receptors to multiple actions of central serotonin systems // Eur. J. Pharmacol., 2004, 488: 1 –9 26. Göthert M. Serotonin discovery and stepwise disclosure of 5-HT receptor complexity over four decades. Part I. General background and discovery of serotonin as a basis for 5-HT receptor identification // Pharmacological Reports, 2013, 65, 771-786 27. Grinberg L.T., Rüb U., Ferretti R.E., Nitrini R., Farfel J.M., Polichiso L., Gierga K., Jacob-Filho W., Heinsen H. The dorsal raphe nucleus shows phospho-tau neurofibrillary changes before the transentorhinal region in Alzheimer ’s disease. A precocious onset? // Neuropathol. Appl. Neurobiol., 2009, 35, 406 –416
66
28. Gross C., Hen R. The developmental origins of anxiety // Nature Reviews Neuroscience, 2004, 5: 545 –52
29. Hale M.W., Shekhar A., Lowry C.A . Development by environment interactions controlling tryptophan hydroxylase expression // J Chem Neuroanat., 2011, 41(4): 219 –226 30. Haney E., Calarge C., Bliziotes M. M. Clinical Implications of Serotonin Regulation of Bone Mass // Translational Endocrinology of Bone , 2013, Pages 189-198 31. Hannon J., Hoyer D. Molecular biology of 5-HT receptors // Behavioural Brain Research, 2008, 195, 198 –213
32. Harvey J.A. Role of the serotonin 5-HT(2A) receptor in learning // Learn. Mem., 2003, 10, 355 –362 33. Heils A., Teufel A., Petri S., Seemann M., Bengel D., Balling U., Riederer P., Lesch K.P. Functional promoter and polyadenylation site mapping of the human serotonin (5-HT) transporter gene // J. Neural Transm. Gen. Sect., 1995, 102: 247-254 34. Heils A., Teufel A., Petri S., Stober G., Riederer P., Bengel D., Lesch K. P. Allelic variation of human serotonin transporter gene expression // J. Neurochem., 1996, 66: 2621-2624 35. Herken H., Erdal M.E., Esgi K., Virit O., Aynacıoğlu A.Ş. The Relationship Between the Response to Risperidone Treatment and 5-HT2A Receptor Gene (T102C and 1438G/A) Polymorphism in Schizophrenia // Bulletin of Clinical Psychopharmacology, 2003, 13:161-166 36. Herzallah M.M., Moustafa A.A., Natsheh J.Y., Abdellatif S.M., Taha M.B., Tayem Y.I., Sehwail M.A., Amleh I., Petrides G., Myers C.E., Gluck M.A. Learning from negative feedback in patients with major depressive disorder is attenuated by SSRI antidepressants // Frontiers in Integrative Neuroscience, 2013, 67(7): 1-9 67
37. Hilaire G., Voituron N., Menuet C., Ichiyama R.M., Subramanian H.H., Dutschmann M. The role of serotonin in respiratory function and dysfunction // Respiratory Physiology & Neurobiology, 2010, 174, 76 –88 38. Honda S., Nakao T., Mitsuyasu H., Okada K., Gotoh L., Tomita M., Sanematsu H., Murayama K., Ikari K., Kuwano M., Yoshiura T., Kawasaki H., Kanba S. A pilot study exploring the association of morphological changes with 5-HTTLPR polymorphism in OCD patients // Annals of General Psychiatry, 2017, 16:2 39. Houwing D.J., Buwalda B., van der Zee E.A., de Boer S.F., Olivier J.D.A. The Serotonin Transporter and Early Life Stress: Translational Perspectives // Front. Cell. Neurosci., 2017, 11:117 40. Hoyer D., Hannon J.P., Martin G.R. Molecular, pharmacological and functional diversity of 5-HT receptors // Pharmacol Biochem Behav.,2002, 71: 533-554 41. http://psychiatricdrugs.com/neurology/serotonin/ 42. http://sportguardian.ru/article/6552/sportivnaya_genetika_geneticheskie_testi_ dlya_sportsmenov 43. https://sapiensoup.com/serotonin#fn:pathway 44. https://www.omim.org/entry/182138?search=5HTT&highlight=5htt#37 45. Hu X.Z., Lipsky R. H., Zhu G., Akhtar L. A., Taubman J., Greenberg B. D., Xu K., Arnold P. D., Richter M. A., Kennedy J. L., Murphy D. L., Goldman D. Serotonin transporter promoter gain-of-function genotypes are linked to obsessive-compulsive disorder // Am. J. Hum. Genet., 2006, 78: 815-826 46. Jacobs B.L., Müller C.P. Handbook of the behavioral neurobiology of serotonin // In Handbook of behavioral neuroscience v 18 (London: Academic Press,), pp. 1 online resource (xv, 818 p.), 2010 47. Jensen P., Farago A.F., Awatramani R.B., Scott M.M., Deneris E.S., Dymecki S.M. Redefining the serotonergic system by genetic lineage // Nature neuroscience, 2008, 11, 417- 419
68
48. Julie G. Hensler. Serotonin transporter gene polymorphism and emotional processing
// Handbook of Behavioral Neuroscience, 2010, 21, 367-378 49. Karen Sugden, Ales Tichopad, Nadeem Khan, Ian W Craig, Ursula M D'Souza. Genes within the serotonergic system are differentially expressed in human brain // BMC Neuroscience, 2009, 10:50 50. Khait V.D., Huang Y.Y., Zalsman G., Oquendo M.A., Brent D.A., Harkavy- Friedman J.M., Mann J.J. Association of serotonin 5-HT2A receptor binding and the T102C polymorphism in depressed and healthy caucasian subjects // Neuropsychopharmacology, 2005, 30, 166 –172
51. Kulikov AV, Naumenko VS, Voronova IP, Tikhonova MA, Popova NK. Quantitative RT-PCR assay of 5-HT1A and 5-HT2A serotonin receptor mRNAs using genomic DNA as an external standard // J Neurosci Methods, 2005, 141: 97-101
52. Lauterbach E.C., Victoroff J., Coburn K.L., Shillcutt S.D., Doonan S.M., Mendez M.F. Psychopharmacological neuroprotection in neurodegenerative disease: assessing the preclinical data // J. Neuropsychiatry Clin. Neurosci., 2010, 22, 8 –18 53. Lesch K.P., Balling U., Gross J., Strauss K., Wolozin B.L., Murphy D.L., Riederer P. Organization of the human serotonin transporter gene // J. Neural Transm. Gen. Sect., 1994, 95: 157-162 54. Lesch K.P., Bengel D., Heils A., et al. Association of anxiety related traits with a polymorphism in the serotonin transporter gene // Science, 1996, 274: 1527- 1531 55. Lesch K.P. Serotonergic gene inactivation in mice: models for anxiety and aggression? // Novartis Found. Symp., 2005, 268: 111 –40
56. Lin M.W., Curtis D., Williams N., Arranz M., Nanko S., Collier D., McGuffin P., Murray R., Owen M., Gill M.
Suggestive evidence for linkage of 69
schizophrenia to markers on chromosome 13q14.1 - q32 // Psychiatr Genet., 1995, 5: 117-26 57. Lopez de Lara C., Dumais A., Rouleau G., Lesage A., Dumont M., Chawky A., Alda M., Benkelfat C., Turecki G. STin2 variant and family history of suicide as significant predictors of suicide completion in major depression // Biol Psychiatry, 2006, 59(2): 114-20 58. Maple A.M., Zhao X., Elizalde D.I., McBride A.K., Gallitano A.L. Htr2a expression responds rapidly to environmental stimuli in an Egr3-dependent manner // ACS Chem. Neurosci., 2015, 6, 1137 –1142 59. Maximino C. Serotonin in the Nervous System of Vertebrates // Serotonin and Anxiety, SpringerBriefs in Neuroscience, 2012, 15-36 60. Nakamura M., Ueno S., Sano A., Tanabe H. The human serotonin transporter gene linked polymorphism (5-HTTLPR) shows ten novel allelic variants // Molecular Psychiatry, 2000, 5: 32 –38 61. Neugroschl J., Sano M. Current treatment and recent clinical research in Al zheimer’s disease. Mt. Sinai J. Med. 2010, 77, 3–16 62. Noreen Goldman, Dana A. Glei, Yu ‐Hsuan Lin, Maxine Weinstein. The Serotonin Transporter Polymorphism (5-HTTLPR): Allelic Variation and Links with Depressive Symptoms // Depress Anxiety, 2010, 27(3): 260 –269 63. Okaty, B.W., Freret, M.E., Rood, B.D., Brust, R.D., Hennessy, M.L., deBairos, D., Kim, J.C., Cook, M.N., Dymecki, S.M. Multi-Scale Molecular Deconstruction of the Serotonin Neuron System // Neuron, 2015, 88, 774-791 64. Pytliak M., Vargová V., Mec hírová V., Felšöci M. Serotonin Receptors - From Molecular Biology to Clinical Applications // Physiological research, 2011, 60: 15-25
65. Rapport M.M., Green A.A., Page I.H. Crystalline Serotonin // Science, 1948b, 108: 329
–330 70
66. Rapport M.M., Green A.A., Page I.H. Partial purification of the vasoconstrictor in beef serum // J Biol Chem., 1948a ,174: 735 –738
67. Rapport M.M., Green A.A., Page I.H. Serum vasoconstrictor, serotonin; isolation and characterization // J. Biol. Chem., 1948, 176 (3): 1243 —51 68. Renda TG: Vittorio Erspamer: a true pioneer in the field of bioactive peptides // Peptides, 2000, 21, 1585 –1586.
69. Rüb U., Del Tredici K., Schultz C., Thal D.R., Braak E., Braak H. The evolution of Alzheimer’s disease-related cytoskeletal pathology in the human raphe nuclei // Neuropathol. Appl. Neurobiol., 2000, 26 (6), 553 –567
70. Sahu A., Gopalakrishnan L.,
Gaur N., Chatterjee O., Mol P.,
Modi P.K., Dagamajalu S.,
Advani J., Jain S., Prasad T.S.K. The 5-Hydroxytryptamine signaling map: an overview of serotonin-serotonin receptor mediated signaling network // J Cell Commun Signal., 2018, 12(4): 731 –735 71. Saiz P.A., Garc ı´a-Portilla M.P., Paredes B., Arango C., Morales B., Alvarez V., Coto E., Bascaran M-T., Bouson˜o M., Bobes J. Association between the A- 1438G polymorphism of the serotonin 2A receptor gene and nonimpulsive suicide attempts // Psychiatric Genetics, 2008, 18: 213 –218
72. Schinka J.A., Busch R.M., Robichaux-Keene N. A meta-analysis of the association between the serotonin transporter gene polymorphism (5-HTTLPR) and trait anxiety // Molec. Psychiat., 2004, 9: 197-202 73. Spohn S.N., Mawe G.M. Non-conventional features of peripheral serotonin signaling // Nat Rev Gastroenterol Hepatol., 2017, 14(7): 412 –420
74. Squires L.N., Jakubowski J.A., Stuart J.N., Rubakhin S.S., Hatcher N.G., Kim W-S., Chen K., Shih J.C., Seif I., Sweedler J.V. Serotonin catabolism and the formation and fate of 5-hydroxyindole thiazolidine carboxylic acid // J Biol Chem, 2006, 281: 13463 –13470 75. Sujitha S.P., Nair A., Banerjee M., Lakshmanan S., Harshavaradhan S., Gunasekaran S., Gopinathan A. 5-Hydroxytryptamine (serotonin) 2A receptor
71
gene polymorphism is associated with schizophrenia // Indian J Med Res, 2014, 140(6): 736 –743
76. Sysoeva O.V., Maluchenko N.V., Timofeeva M.A., Portnova G.V., Kulikova M.A., Tonevitsky A.G. et al. Aggression and 5HTT polymorphism in females: Study of synchronized swimming and control groups // International Journal of Psychophysiology, 2009, 72: 173 –8 77. Tripp A., Sibille E. SERT models of emotional dysregulation // In: Kalueff AV, LaPorte JK (eds) Experimental models in serotonin transporter research. Cambridge University Press, New York, 2010, 105 –134 78. Twarog B. M., Page I. H. Serotonin content of some mammalian tissues and urine and a method for its determination // Am J Physiol, 1953 175(1): 157-61 79. Uçok A., Alpsa n H., Çakır S., Saruhan-Direskeneli G. Association of a serotonin receptor 2a gene polymorphism with cognitive functions in patients with schizophrenia // American Journal of Medical Genetics Part B, 2007, 144(5): 704 –707 80. Ulucan K ., Yalçın S., Akbaş B., Uyumaz F., Konuk M. Analysis of solute carrier family 6 member 4 gene promoter polymorphism in young Turkish basketball players // The journal of Neurobehavioral sciences, 2014, Volume:1, Issue Number:2 81. Vincenzo De Luca, Gwyneth Zai, Subi Tharmalingam, Andrea de Bartolomeis, Greg Wong, James L.Kennedy. Association study between the novel functional polymorphism of the serotonin transporter gene and suicidal behaviour in schizophrenia // Eur Neuropsychopharmacol, 2006, 16(4): 268-71 82. Vyas N.S., Lee Y., Ahn K., Ternouth A., Stahl D.R., Al-Chalabi A., Powell J.F., Puri B.K. Association of a serotonin receptor 2A gene polymorphism with visual sustained attention in early-onset schizophrenia patients and their non-psychotic siblings // Aging Dis., 2012, 3, 291 –300
72
83. Walther D.J., Bader M. A unique central tryptophan hydroxylase isoform // Biochemical Pharmacology, 2003, 66: 1673-1680 84. Whitaker-Azmitia P.M. The Discovery of Serotonin and its Role in Neuroscience // Neuropsychopharmacology, 1999, 21, 2 –8
85. Yadav V.K., Ryu J.H., Suda N., Tanaka K.F., Gingrich J.A., Schütz G., Glorieux F.H., Chiang C.Y., Zajac J.D., Insogna K.L., Mann J.J., Hen R., Ducy P., Karsenty G. Lrp5 controls bone formation by inhibiting serotonin synthesis in the duodenum // Cell, 2008, 135(5): 825-37 86. Yildiz S.H., Akilli A., Bagcioglu E., Erdogan M.O., Coskun K.S., Alpaslan A.H., Subasi B., Terzi A.E.S. Association of schizophrenia with T102C (rs6313) and 1438 a/g (rs6311) polymorphisms of HTR2A gene // Acta Neuropsychiatr., 2013, 25, 342
–348 87. Zhang G., Stackman Jr R.W. The role of serotonin 5-HT2A receptors in memory and cognition // Front. Pharmacol., 2015,
6:225 88. Zhang X., Wang L., Huang F., LI J., Xiong L., XUE H., Zhang Y. Evaluation of the promoter region polymorphism (5-HTTLPR) in the serotonin transporter gene in females with postpartum depression // Experimental and Therapeutic medicine, 2015,
9: 245-249 89. Zill P., Buttner A., Eisenmenger W., Moller H.J., Ackenheil M., Bondy B. Analysis of tryptophan hydroxylase I and II mRNA expression in the human brain: A post-mortem study // Journal of Psychiatric Research, 2007, 41: 168- 173
|